- Report
- August 2023
- 51 Pages
Saudi Arabia
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Colombia
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
United States
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Netherlands
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Germany
From €529EUR$600USD£458GBP
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Japan
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Israel
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Mexico
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Canada
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Italy
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
China
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
France
From €529EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Brazil
From €529EUR$600USD£458GBP
- Report
- September 2022
- 33 Pages
Global
From €878EUR$995USD£760GBP
- Report
- May 2024
- 40 Pages
Global
From €613EUR$695USD£531GBP
- Drug Pipelines
- April 2023
- 34 Pages
Global
From €8815EUR$9,995USD£7,631GBP
- Report
- June 2025
- 80 Pages
From €3043EUR$3,450USD£2,634GBP
- Report
- January 2024
- 150 Pages
Global
€4405EUR$4,995USD£3,814GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more